Who invested in ViaCyte

8 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$188Mraised across 8 rounds since 2006, from 8 sources

$20MVenture$25MSeries C$11MSeries C$5.4MSeries C$20MSeries D$17MGrant$10MRound$80MSeries D

Latest round: Series D, $80MNov 2018
Step-upi: 8×
Investors: 14

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2006200820102012201420162018

$20MVenture$25MSeries C$11MSeries C$5.4MSeries C$17MGrant$10MRound$80MSeries D

First round: Venture, $20M
Biggest round: $80M
Usual gap between rounds: 18 months

The rounds

Nov 2018
Series D$80M2 new1 returning
- RA Capital Management
- Sanderling Ventures
- Bain Capital Life Sciences/ TPG
Reported by ViacyteSEC filing: $36M sold, first sale Nov 2018
May 2017
Round$10M3 new
- Asset Management
- JDRF
- W.L. Gore
Reported by FinSMEs
Sept 2014
Grant$17M1 new
- California Institute For Regenerative Medicine
From a historical funding recordSEC filing: $15M sold, first sale Aug 2014
Aug 2014
Series D$20M
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Aug 2014
Aug 2014
Series C$5.4M
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Aug 2014
Jul 2013
Series C$11M2 returning
- Johnson & Johnson Development Corporation (JJDC)
- Sanderling Ventures
Reported by pehub.comSEC filing: $12M sold, first sale Jul 2013
Jul 2007
Series C$25M4 returning
Reported by novocell.com
May 2006
Venture$20M8 new
From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2006Series C2007Series C2013Series C2014Series D2014Grant2014Round2017Series D2018

Sanderling Ventures

Johnson & Johnson Development Corporation (JJDC)

Asset Management VenturesPacific Horizon Ventures

RA Capital Management

The Vertical GroupDFJ Portage VenturesHeadland Ventures

BD Venture

California Institute For Regenerative Medicine

Everyone who backed them

Sanderling VenturesVC firm4rounds

Johnson & Johnson Development Corporation (JJDC)VC firm3rounds

Asset Management VenturesVC firm2rounds

Pacific Horizon VenturesGrowth equity2rounds

RA Capital ManagementPrivate equity1round

The Vertical GroupVC firm1round

DFJ Portage VenturesVC firm1round

Headland VenturesVC firm1round

BD VentureVC firm1round

California Institute For Regenerative MedicineVC firm1round

Asset Managementno record of our own yet1round

Bain Capital Life Sciences/ TPGno record of our own yet1round

JDRFno record of our own yet1round

W.L. Goreno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about ViaCyte

Who invested in ViaCyte?

ViaCyte's investors include Sanderling Ventures, Johnson & Johnson Development Corporation (JJDC), Asset Management Ventures, Pacific Horizon Ventures and RA Capital Management, and 9 more on record.

How much has ViaCyte raised?

ViaCyte has raised $188M across 8 rounds since 2006.

When did ViaCyte last raise?

ViaCyte's most recent round was a Series D of $80M in Nov 2018.

What was ViaCyte's biggest round?

Its most recent round, $80M in Nov 2018, is also its largest on record.

Who backed ViaCyte first?

ViaCyte's first round on record, in May 2006, was backed by Johnson & Johnson Development Corporation (JJDC), Asset Management Ventures and Sanderling Ventures and 5 others.